Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Appointed director
|
|
CERUS CORP (CERS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/10/2019 |
GN
| New Research Coverage Highlights Fortive, Pieris Pharmaceuticals, CEVA, ManTech International, Cerus, and NN — Consolidated Revenues, Company Growth, and Expectations for 2019 |
| 02/14/2019 |
GN
| Consolidated Research: 2019 Summary Expectations for Varonis, Dolby Laboratories, Alder BioPharmaceuticals, Retail Properties of America, Cerus, and Motorcar Parts of America — Fundamental Analysis, Key Performance Indications |
| 11/22/2017 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within REV Group, CoreLogic, M/I Homes, Halyard Health, Deckers Outdoor, and Cerus — New Research Emphasizes Economic Growth |
| 04/07/2017 |
GN
| Cerus Corporation (Nasdaq: CERS) to Ring the Nasdaq Stock Market Closing Bell Remotely from the Nasdaq Entrepreneurial Center in San Francisco |
|
|